Pharmaceutical Investing Iterum Initiates SURE 2 and SURE 3 Phase 3 Clinical Trials of IV and Oral Sulopenem in Complicated Urinary Tract and Complicated Intra-abdominal Infections
Pharmaceutical Investing Iterum Initiates SURE 1, a Phase 3 Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infections
Juggernaut Further Increases Oversubscribed Financing to $9,557,000 due to Tremendous Strong Demand from Institutions and Accredited Investors
CoTec Holdings Corp. To Commence Expansion Drilling Program And Secure A Salter Techology Bulk Sample At The Lac Jeannine Property
